I mentioned cenciviroc from Takeda a few weeks ago and one of our doctors or science people explained how the MOA of leronlimab was superior.

I agree with you that it was likely that Nader was approached.

He does not seem to "play well with others."

That being said, if their cocktail works out, what would stop leronlimab from being an alternate ingredient?